Go Pro
TSE:ACB

Aurora Cannabis Q3 2026 Earnings Report

Aurora Cannabis logo
C$5.94 -0.06 (-1.00%)
As of 09/23/2026 04:00 PM Eastern

Aurora Cannabis EPS Results

Actual EPS
C$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Aurora Cannabis Revenue Results

Actual Revenue
$94.19 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aurora Cannabis Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Aurora Cannabis Earnings Headlines

Aurora Cannabis extends gains for seventh straight session
They're shrinking your dollars every single month
Since 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about what $375,000 did five years ago, even though no statement shows the change. Central banks have bought over 1,000 tonnes of gold a year for three straight years, using the same published data now explained in a free guide. The guide breaks down what's driving the shift in plain English, so readers can see the numbers for themselves.tc pixel
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora Cannabis (TSE:ACB), headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

View Aurora Cannabis Profile